Image-based 384-well high-throughput screening method for the discovery of skyllamycins A to C as biofilm inhibitors and inducers of biofilm detachment in Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 2, 2014, Pages 1092-1099

  Navarro, Gabriel ^a   Cheng, Andrew T ^a   Peach, Kelly C ^a   Bray, Walter M ^a   Bernan, Valerie S ^b   Yildiz, Fitnat H ^a   Linington, Roger G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Carter Bernan Consulting   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; AZITHROMYCIN; CYCLODEPSIPEPTIDE; GREEN FLUORESCENT PROTEIN; MACROLIDE; POLYMYXIN B; SKYLLAMYCIN A; SKYLLAMYCIN B; SKYLLAMYCIN C; TETRACYCLINE; UNCLASSIFIED DRUG;

ARTICLE; BIOFILM; CONTROLLED STUDY; DRUG POTENTIATION; DRUG SCREENING; EPIFLUORESCENCE MICROSCOPY; HIGH THROUGHPUT SCREENING; IMAGE ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STREPTOMYCES;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BACTERIAL ADHESION; BIOFILMS; DEPSIPEPTIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; DRUG SYNERGISM; FLUORESCENT DYES; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HIGH-THROUGHPUT SCREENING ASSAYS; MOLECULAR IMAGING; PATTERN RECOGNITION, AUTOMATED; PEPTIDES, CYCLIC; PSEUDOMONAS AERUGINOSA;

EID: 84893515743     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01781-13     Document Type: Article

References (39)

1. Costerton JW, Stewart PS, Greenberg EP. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322. http://dx.doi.org/10.1126/science.284.5418.1318.
2. Wingender J, Neu T, Flemming H. 1999. What are bacterial extracellular polymeric substances?, p 1-19. In Wingender J, Neu T, Flemming H (ed), Microbial extracellular polymeric substance characterization, structure and function, 1st ed. Springer, Berlin, Germany.
3. Hall-Stoodley L, Costerton JW, Stoodley P. 2004. Bacterial biofilms: from the natural environment to infectious diseases. Nat. Rev. Microbiol. 2:95-108. http://dx.doi.org/10.1038/nrmicro821.
4. Lynch AS, Robertson GT. 2008. Bacterial and fungal biofilm infections. Annu. Rev. Med. 59:415-428. http://dx.doi.org/10.1146/annurev.med.59.110106. 132000.
5. Fux CA, Costerton JW, Stewart PS, Stoodley P. 2005. Survival strategies of infectious biofilms. Trends Microbiol. 13:34-40. http://dx.doi.org/10.1016/j. tim.2004.11.010.
6. Donlan RM. 2001. Biofilms and device-associated infections. Emerg. Infect. Dis. 7:277-281. http://dx.doi.org/10.3201/eid0702.010226.
7. Khoury AE, Lam K, Ellis B, Costerton JW. 1992. Prevention and control of bacterial infections associated with medical devices. ASAIO J. 38: M174-M178. http://dx.doi.org/10.1097/00002480-199207000-00013.
8. Scott RD. 2009. The direct medical costs of healthcare-associated infections in US hospitals and the benefits of prevention. National Center for Preparedness, Detection, and Control of Infectious Diseases (U.S.), Division of Healthcare Quality Promotion, Atlanta, GA.
9. Franklin MJ, Nivens DE, Weadge JT, Howell PL. 2011. Biosynthesis of the Pseudomonas aeruginosa extracellular polysaccharides, alginate, Pel, and Psl. Front. Microbiol. 2:167. http://dx.doi.org/10.3389/fmicb.2011.00167.
10. Obritsch MD, Fish DN, MacLaren R, Jung R. 2005. Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options. Pharmacotherapy 25:1353-1364. http://dx.doi.org/10.1592/phco.2005.25. 10.1353.
11. Smith JJ, Travis SM, Greenberg EP, Welsh MJ. 1996. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 85:229-236. http://dx.doi.org/10.1016/S0092-8674(00)81099-5.
12. Donlan RM, Costerton JW. 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15:167-193. http://dx.doi.org/10.1128/CMR.15.2.167-193.2002.
13. Müsken M, DiFiore S, Römling U, Häussler S. 2010. A 96-well-platebased optical method for the quantitative and qualitative evaluation of Pseudomonas aeruginosa biofilm formation and its application to susceptibility testing. Nat. Protoc. 5:1460-1469. http://dx.doi.org/10.1038/ nprot.2010.110.
14. O'Toole GA, Kolter R. 1998. Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol. Microbiol. 28:449-461. http://dx.doi.org/10. 1046/j.1365-2958.1998.00797.x.
15. Müsken M, DiFiore S, Dötsch A, Fischer R, Häussler S. 2010. Genetic determinants of Pseudomonas aeruginosa biofilm establishment. Microbiology 156:431-441. http://dx.doi.org/10.1099/mic.0.033290-0.
16. Peng F, Hoek EMV, Damoiseaux R. 2010. High-content screening for biofilm assays. J. Biomol. Screen. 15:748-754. http://dx.doi.org/10.1177/ 1087057110374992.
17. Junker LM, Clardy J. 2007. High-throughput screens for small-molecule inhibitors of Pseudomonas aeruginosa biofilm development. Antimicrob. Agents Chemother. 51:3582-3590. http://dx.doi.org/10.1128/AAC.00506-07.
18. Sandberg M, Määttänen A, Peltonen J, Vuorela PM, Fallarero A. 2008. Automating a 96-well microtitre plate model for Staphylococcus aureus biofilms: an approach to screening of natural antimicrobial compounds. Int. J. Antimicrob. Agents 32:233-240. http://dx.doi.org/10.1016/j.ijantimicag.2008.04. 022.
19. Peach KC, Bray WM, Shikuma NJ, Gassner NC, Lokey RS, Yildiz FH, Linington RG. 2011. An image-based 384-well high-throughput screening method for the discovery of biofilm inhibitors in Vibrio cholerae. Mol. Biosyst. 7:1176-1184. http://dx.doi.org/10.1039/c0mb00276c.
20. Pohle S, Appelt C, Roux M, Fiedler H-P, Süssmuth RD. 2011. Biosynthetic gene cluster of the non-ribosomally synthesized cyclodepsipeptide skyllamycin: deciphering unprecedented ways of unusual hydroxylation reactions. J. Am. Chem. Soc. 133:6194-6205. http://dx.doi.org/10.1021/ja108971p.
21. Toki S, Agatsuma T, Ochiai K, Saitoh Y, Ando K, Nakanishi S, Lokker NA, Giese NA, Matsuda Y. 2001. RP-1776, a novel cyclic peptide produced by Streptomyces sp., inhibits the binding of PDGF to the extracellular domain of its receptor. J. Antibiot. (Tokyo) 54:405-414. http://dx.doi.org/10.7164/ antibiotics.54.405.
22. Peach KC, Cheng AT, Oliver AG, Yildiz FH, Linington RG. 17 September 2013. Discovery and biological characterization of the auromomycin chromophore as an inhibitor of biofilm formation in Vibrio cholerae. Chembiochem 16:2209-2215. http://dx.doi.org/10.1002/cbic.201300131.
23. Wong WR, Oliver AG, Linington RG. 2012. Development of antibiotic activity profile screening for the classification and discovery of natural product antibiotics. Chem. Biol. 19:1483-1495. http://dx.doi.org/10.1016/j. chembiol.2012.09.014.
24. Schulze CJ, Bray WM, Woerhmann MH, Stuart J, Lokey RS, Linington RG. 2013. "Function-first" lead discovery: mode of action profiling of natural product libraries using image-based screening. Chem. Biol. 20: 285-295. http://dx.doi.org/10.1016/j.chembiol.2012.12.007.
25. Watanabe K, Kodama Y, Harayama S. 2001. Design and evaluation of PCR primers to amplify bacterial 16S ribosomal DNA fragments used for community fingerprinting. J. Microbiol. Methods 44:253-262. http://dx.doi.org/10.1016/ S0167-7012(01)00220-2.
26. Tunney MM, Ramage G, Field TR, Moriarty TF, Storey DG. 2004. Rapid colorimetric assay for antimicrobial susceptibility testing of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 48:1879-1881. http://dx.doi.org/10. 1128/AAC.48.5.1879-1881.2004.
27. Kirisits MJ, Prost L, Starkey M, Parsek MR. 2005. Characterization of colony morphology variants isolated from Pseudomonas aeruginosa biofilms. Appl. Environ. Microbiol. 71:4809-4821. http://dx.doi.org/10.1128/AEM.71.8.4809-4821. 2005.
28. D'Argenio DA, Calfee MW, Rainey PB, Pesci EC. 2002. Autolysis and autoaggregation in Pseudomonas aeruginosa colony morphology mutants. J. Bacteriol. 184:6481-6489. http://dx.doi.org/10.1128/JB.184.23.6481-6489.2002.
29. Donlan RM. 2002. Biofilms: microbial life on surfaces. Emerg. Infect. Dis. 8:881-890. http://dx.doi.org/10.3201/eid0809.020063.
30. Feeley TW, Du Moulin GC, Hedley-Whyte J, Bushnell LS, Gilbert JP, Feingold DS. 1975. Aerosol polymyxin and pneumonia in seriously ill patients. N. Engl. J. Med. 293:471-475. http://dx.doi.org/10.1056/NEJM197509042931003.
31. Hoffman LR, D'Argenio DA, MacCoss MJ, Zhang Z, Jones RA, Miller SI. 2005. Aminoglycoside antibiotics induce bacterial biofilm formation. Nature 436:1171-1175. http://dx.doi.org/10.1038/nature03912.
32. Lewis K. 2007. Persister cells, dormancy and infectious disease. Nat. Rev. Microbiol. 5:48-56. http://dx.doi.org/10.1038/nrmicro1557.
33. Bhushan R, Brückner H. 2004. Marfey's reagent for chiral amino acid analysis: a review. Amino Acids 27:231-247. http://dx.doi.org/10.1007/s00726- 004-0118-0.
34. Huigens RW, Richards JJ, Parise G, Ballard TE, Zeng W, Deora R, Melander C. 2007. Inhibition of Pseudomonas aeruginosa biofilm formation with bromoageliferin analogues. J. Am. Chem. Soc. 129:6966-6967. http://dx.doi.org/ 10.1021/ja069017t.
35. Reyes S, Huigens RW, Su Z, Simon ML, Melander C. 2011. Synthesis and biological activity of 2-aminoimidazole triazoles accessed by Suzuki-Miyaura cross-coupling. Org. Biomol. Chem. 9:3041-3049. http://dx.doi.org/10.1039/ c0ob00925c.
36. Geske GD, O'Neill JC, Miller DM, Mattmann ME, Blackwell HE. 2007. Modulation of bacterial quorum sensing with synthetic ligands: systematic evaluation of N-acylated homoserine lactones in multiple species and new insights into their mechanisms of action. J. Am. Chem. Soc. 129: 13613-13625. http://dx.doi.org/10.1021/ja074135h.
37. Geske GD, Wezeman RJ, Siegel AP, Blackwell HE. 2005. Small molecule inhibitors of bacterial quorum sensing and biofilm formation. J. Am. Chem. Soc. 127:12762-12763. http://dx.doi.org/10.1021/ja0530321.
38. Stowe SD, Richards JJ, Tucker AT, Thompson R, Melander C, Cavanagh J. 2011. Anti-biofilm compounds derived from marine sponges. Mar. Drugs 9:2010-2035. http://dx.doi.org/10.3390/md9102010.
39. Worthington RJ, Richards JJ, Melander C. 2012. Small molecule control of bacterial biofilms. Org. Biomol. Chem. 10:7457-7474. http://dx.doi.org/10.1039/ c2ob25835h.